Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITAN: Lefitolimod and bNAbs in HIV-1 Infection
NCT03837756Phase 2Completed
- Sponsor
- Aarhus University
- Start
- May 2019
- Primary completion
- Jul 2022
- Modality
- Antisense DNA, Prophylactic Vaccines, Small Interfering RNA (siRNA)
- Countries
- 4
01
Overview
A Phase 2 trial of lefitolimod, Teropavimab, zinlirvimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Aarhus University. Started May 2019; status: completed.
02
Drugs
lefitolimodTeropavimabzinlirvimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03837756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03837756.